and blogs are the Official Website for the books:  Parkinson's Treatment: 10 Secrets to a Happier Life and 10 Breakthrough Therapies for Parkinson's Disease.

Dr. Okun is the co-founder of the University of Florida Center for Movement Disorders and Neurorestoration, the National Medical Director for the National Parkinson Foundation, as well as the author of several books including Ask the Expert about Parkinson's Disease, Lessons from the Bedside, 10 Breakthrough Therapies for Parkinson's Disease and Parkinson's Treatment: 10 Secrets to a Happier life due out in 2013.  His secrets book was translated into 20 languages so that it can be made available to Parkinson's disease sufferers around the world.  Dr. Okun has been recently been honored at the White House as a Champion of Change for Parkinson's Disease. Dr. Okun has been published in journals such as the New England Journal of Medicine and people travel from around the world to seek his opinion on best treatment approaches for this disease.

Is Hepatitis C a Risk Factor for Parkinson's Disease

An article came out this morning on hepatitis C and risk of the development of Parkinson's Disease.  The full summary can be obtained at Journal Watch Neurology where Dr. Okun is an Associate Editor.  Here is a teaser.

Tsai and colleagues sought to investigate whether hepatitis C virus (HCV) infection was a risk factor for the later development of Parkinson disease (PD).  The authors used data from the Taiwan National Health Insurance Research Database.  The association between HCV and the later development of PD was the strongest , even after adjusting for age, sex, and comorbidities. The authors concluded that HCV infection increased the risk of the later development of PD. The idea that viruses such as HCV can cross the blood brain barrier and lead to nigral degeneration and Parkinson’s symptoms is not new, however this study is one of the few to offer well documented evidence of at least an association. The study is strengthened by the large sample size, however the results must be interpreted cautiously because of the lack of diagnostic certainty of PD, and because of the missing details; such as transfusion history, drug abuse, and other potentially important factors. Clinicians should be aware that a diagnosis of HCV may be a risk factor for the later development of PD.  The threshold for ordering a neurological consultation in HCV cases should be lower.